A New Perspective in Drug Discovery

What We Do

A native mass spectrometry platform providing a new perspective in drug discovery

Oxford Mass Technologies (OMass) specializes in applying mass spectrometry to the characterisation of intact protein assemblies, a technique often referred to as native mass spectrometry. By preserving the structures of protein assemblies, we are able to provide structural insights into large, dynamic complexes.

Our recent technological breakthroughs in native mass spectrometry of membrane proteins enable new applications of the technique to high-value receptors and drug targets which are challenging for other biophysical techniques.

We provide our technology and know-how to assist biotechnology and pharmaceutical companies in tackling challenging drug targets and biotherapeutics, within a dynamic and collaborative framework.